Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 13;8(7):6669-6678.
doi: 10.1021/acsomega.2c07256. eCollection 2023 Feb 21.

Design, Synthesis, and Biological Evaluation Studies of Novel Naphthalene-Chalcone Hybrids As Antimicrobial, Anticandidal, Anticancer, and VEGFR-2 Inhibitors

Derya Osmaniye  1   2 , Begüm Nurpelin Sağlık  1   2 , Narmin Khalilova  1 , Serkan Levent  1   2 , Gizem Bayazıt  3 , Ülküye Dudu Gül  3 , Yusuf Özkay  1   2 , Zafer Asım Kaplancıklı  1
Affiliations

Design, Synthesis, and Biological Evaluation Studies of Novel Naphthalene-Chalcone Hybrids As Antimicrobial, Anticandidal, Anticancer, and VEGFR-2 Inhibitors

Derya Osmaniye et al. ACS Omega. .

Abstract

Cancer is a progressive disease that is frequently encountered worldwide. The incidence of cancer is increasing with the changing living conditions around the world. The side-effect profile of existing drugs and the resistance developing in long-term use increase the need for novel drugs. In addition, cancer patients are not resistant to bacterial and fungal infections due to the suppression of the immune system during the treatment. Rather than adding a new antibacterial or antifungal drug to the current treatment plan, the fact that the drug with anticancer activity has these effects (antibacterial and antifungal) will increase the patient's quality of life. For this purpose, in this study, a series of 10 new naphthalene-chalcone derivatives were synthesized and their anticancer-antibacterial-antifungal properties were investigated. Among the compounds, compound 2j showed activity against the A549 cell line with an IC50 = 7.835 ± 0.598 μM. This compound also has antibacterial and antifungal activity. The apoptotic potential of the compound was measured by flow cytometry and showed apoptotic activity of 14.230%. The compound also showed 58.870% mitochondrial membrane potential. Compound 2j inhibited VEGFR-2 enzyme with IC50 = 0.098 ± 0.005 μM. Molecular docking studies of the compounds were carried out by in silico methods against VEGFR-2 and caspase-3 enzymes.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Some VEGFR inhibitors.
Scheme 1
Scheme 1. Synthesis Pathway for Obtained Compounds (2a–2j)
Figure 2
Figure 2
Flow cytometric analysis quadrants of compound 2j and SD4.
Figure 3
Figure 3
Analysis of mitochondrial membrane potential of compound 2j and SD4.
Figure 4
Figure 4
Molecular docking of VEGFR-2 enzymes (PDB code: 4ASE and PDB Code: 4ASD) and Caspase-3 enzyme (PDB code: 4QTX) with compound 2j. (A) The three-dimensional interacting mode of compound 2j in the active region of VEGFR-2 enzyme (PDB ID: 4ASE). (B) 3D docking pose of compound 2j with the key amino acids within the binding pocket of 4ASE is shown: aromatic hydrogen bonds with blue dashed lines, hydrogen bonds with yellow dashed lines, and salt bridge with purple dashed lines. (C) The three-dimensional interacting mode of compound 2j in the active region of VEGFR-2 enzyme (PDB ID: 4ASD). (D) 3D docking pose of compound 2j with the key amino acids within the binding pocket of 4ASD is shown: aromatic hydrogen bonds with blue dashed lines, hydrogen bonds with yellow dashed lines, and salt bridge with purple dashed lines. (E) The three-dimensional interacting mode of compound 2j in the active region of Caspase-3 enzyme (PDB ID: 4QTX). (F) 3D docking pose of compound 2j with the key amino acids within the binding pocket of 4QTX is shown: aromatic hydrogen bonds with blue dashed lines, hydrogen bonds with yellow dashed lines and cation–pi interaction with dark green dashed lines, pi–pi interaction with green dashed lines.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. El Ghalia H.; Amina G.; El Aissouq A.; Oussama C.; Hicham E. H.; Abdelkrim O.; Mohammed B. A quantitative study of the structure-activity relationship and molecular docking of 5.6. 7-trimethoxy-N-aryl-2-styrylquinolin-4-amines as potential anticancer agents using quantum chemical descriptors and statistical methods. J. Mol. Struct. 2022, 1270, 133794.10.1016/j.molstruc.2022.133794. - DOI
    1. Qi B.; Wang F.; He H.; Fan M.; Hu L.; Xiong L.; Gong G.; Shi S.; Song X. Identification of (S)-1-(2-(2, 4-difluorophenyl)-4-oxothiazolidin-3-yl)-3-(4-((7-(3-(4-ethylpiperazin-1-yl) propoxy)-6-methoxyquinolin-4-yl) oxy)-3, 5-difluorophenyl) urea as a potential anti-colorectal cancer agent. Eur. J. Med. Chem. 2022, 239, 114561.10.1016/j.ejmech.2022.114561. - DOI - PubMed
    1. Engle K.; Kumar G. Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update. Eur. J. Med. Chem. 2022, 239, 114542.10.1016/j.ejmech.2022.114542. - DOI - PubMed
    1. JawalePatil P. D.; Bhamidipati K.; Damale M. G.; Sangshetti J. N.; Puvvada N.; Bhosale R. S.; Ingle R. D.; Pawar R. P.; Bhosale S. V.; Bhosale S. V. Synthesis of naphthalimide derivatives bearing benzothiazole and thiazole moieties: In vitro anticancer and in silico ADMET study. J. Mol. Struct. 2022, 1263, 133173.10.1016/j.molstruc.2022.133173. - DOI
    1. Pérez-Soto M.; Peñalver P.; Street S. T.; Weenink D.; O’Hagan M. P.; Ramos-Soriano J.; Jiang Y. J.; Hollingworth G. J.; Galan M. C.; Morales J. C. Structure-activity relationship studies on divalent naphthalene diimide G quadruplex ligands with anticancer and antiparasitic activity. Bioorg. Med. Chem. 2022, 71, 116946.10.1016/j.bmc.2022.116946. - DOI - PubMed
    2. Wang X.; Lu Y.; Sun D.; Qian J.; Tu S.; Yue W.; Lin H.; Tang H.; Meng F.; He Q.; et al. Discovery of 4-methoxy-N-(1-naphthyl) benzenesulfonamide derivatives as small molecule dual-target inhibitors of tubulin and signal transducer and activator of transcription 3 (STAT3) based on ABT-751. Bioorg. Chem. 2022, 125, 105864.10.1016/j.bioorg.2022.105864. - DOI - PubMed
    3. Gurung S. K.; Kumari S.; Dana S.; Mandal K.; Sen S.; Mukhopadhyay P.; Mondal N. DNA damage, cell cycle perturbation and cell death by naphthalene diimide derivative in gastric cancer cells. Chem-Bio. Interact. 2022, 358, 109881.10.1016/j.cbi.2022.109881. - DOI - PubMed
    4. Husseiny E.; El menofy N.; El-Sebaey S. 1,8-Diaminonaphthalene-derived pharmacophore as potent anti-MRSA with dual DNA gyrase and topoisomerase IV inhibition. Egypt. J. Chem. 2021, 65 (3), 1–17. 10.21608/ejchem.2021.104410.4824. - DOI
    5. Alorini T. A.; Al-Hakimi A. N.; El-Sayed Saeed S.; Alhamzi E. H. L.; Albadri A. E. A. E. Synthesis, characterization, and anticancer activity of some metal complexes with a new Schiff base ligand. Arab. J. Chem. 2022, 15 (2), 103559.10.1016/j.arabjc.2021.103559. - DOI

LinkOut - more resources